Read news as it happens
Create a Rediffmail account
Subscribe via RSS
3rd wave: Govt creating 30-day stock of key Covid medicines
'The Centre is planning to procure five million vials of Remdesivir ahead of the third wave. What’s better is that this time, the government is paying us in advance,' said a senior executive......
Zydus Cadila to begin vaccine trials for kids above 5 yrs soon
So far, no other vaccine has been approved globally for children below 12 years.Sohini Das reports. IMAGE: A beneficiary receives a dose of the Covid-19 vaccine at a vaccination centre in......
Zydus Cadila seeks nod for its COVID vaccine for 12 years, above
Drug firm Zydus Cadila on Thursday said it has applied for emergency use authorisation (EUA) with the Indian drug regulator for its three-dose COVID-19 vaccine ZyCoV-D, and plans to manufacture......
India's children may get 2 Covid vaccines by December
While Bharat Biotech’s Covaxin is in trials among children already, Serum Institute of India will begin Novavax vaccine trials on children from July, whereas the Pfizer vaccine has been......
India could get 4th Covid vaccine as Zydus Cadila set to seek nod for ZyCoV-D
This could also be India's first vaccine for children aged 12 years and above as the company has conducted trials on the age group. The decision, however, lies with the regulator, reports Sohini......
How Indian pharma bounced back from lockdown lows
From rising prescriptions to the pharma sales force back on the field with full vigour and companies finally finding their feet with the digital marketing strategies — Indian drug makers have......
4 Indian drug firms recall products in US market
Indian drug firms like Marksans Pharma, Aurobindo Pharma, Zydus and Jubilant are recalling products in the US market, as per the latest enforcement report by the US Food and Drug......
Govt gifts Rs 1.45-trillion incentive for 10 manufacturing sectors
The government hopes that the PLI schemes would provide 200,000-300,000 direct employment over five years, according to sources in the know. In a move that has lifted the industry sentiment in the......
Covid drug sales shine even as market slows
Fabiflu sales have grown by 62 per cent in July. It was launched in June. This drug is being used by doctors for mild-to-moderate Covid patients even if they are in home isolation. Even as the......
Another Indian COVID-19 vaccine candidate gets nod for human trial
Zydus plans to initiate the clinical trials of ZyCoV-D in July 2020 across multiple sites in India. In animal studies the vaccine was found to elicit a strong immune response in multiple animal......
bharatiya janata party
united progressive alliance
national democratic alliance
rashtriya swayamsevak sangh
central bureau of investigation
Top Coverage News
US Presidential Elections 2016
Coming to India and making
Success in manufacturing is not just about being cheap - cheap labour, cheap land, cheap power...
India, through the eye of a camera
Commonwealth Games - 2014
The defence coverage of Rediff.com
Office email App
© 2021 Rediff.com